239
Views
4
CrossRef citations to date
0
Altmetric
Research Report

Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand

, , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Krittaphas Kangwanrattanakul. (2022) A systematic review of health state utility values in Thai cancer patients. Expert Review of Pharmacoeconomics & Outcomes Research 22:8, pages 1171-1186.
Read now
Kankamon Kittrongsiri, Worawit Wanitsuwan, Paradee Prechawittayakul, Sermsiri Sangroongruangsri, John Cairns & Usa Chaikledkaew. (2020) Survival analysis of colorectal cancer patients in a Thai hospital-based cancer registry. Expert Review of Gastroenterology & Hepatology 14:4, pages 291-300.
Read now

Articles from other publishers (2)

Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman & Koen Degeling. (2023) Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Yot Teerawattananon & Alia Luz. (2015) Health Technology Assessment as a Priority-Setting Tool for Universal Health Coverage: The Call for Global Action at the Prince Mahidol Award Conference 2016. PharmacoEconomics 34:1, pages 1-3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.